Stay updated on Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, reflecting a newer release of the page.SummaryDifference0.1%

- Check9 days agoChange DetectedOn 2026-06-15, the record added new sections for Study Status, Contacts/Locations, and References. The update expands the page with current status details, contact information, and related references.SummaryDifference0.4%

- Check16 days agoChange DetectedTwo new user-facing options were added: 'Check who can join' and 'Find Contact Information', along with a revision tag 'v3.6.0'. These changes provide easier access to eligibility guidance and study contact details within the record.SummaryDifference0.3%

- Check23 days agoChange DetectedA new revision label, v3.5.5, appears on the history page as the latest entry. This marks a minor platform update rather than a change to study content.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded a new version entry on 2026-05-18 with an updated Study Status. An older entry from 2026-04-20 was removed, updating the version history to reflect the latest status change in the record.SummaryDifference0.2%

- Check44 days agoChange DetectedA new revision entry labeled v3.5.4 appears in the record history, replacing the prior v3.5.3. This reflects a minor site-build update to the page.SummaryDifference0.1%

Stay in the know with updates to Divarasib Combo in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Divarasib Combo in KRAS G12C NSCLC Clinical Trial page.